Therapeutics

Logo Benzinga
Business / FinanceBy Business Wire2023-10-31 12:32:00
DiaMedica Therapeutics Inc. DMAC, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-10-27 20:03:00
- Total quarterly revenue of $217 million, representing 57% year-over-year growth - - 2022 DMD revenue guidance and low end of total revenue guidance...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-11-08 13:00:00
Ovid intends to initiate a Phase 1 study in healthy volunteers in Q4 2022, following the FDA clearance of an Investigational New Drug (IND) application for...

Logo Benzinga
MarketsBy Vandana Singh2023-10-31 15:39:23
Hoth Therapeutics Inc HOTH announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis. Using the SCORAD as a...

Logo Benzinga
MarketsBy Vandana Singh2023-11-04 14:35:48
Rain Therapeutics Inc RAIN announced preliminary data from Phase 2 basket trial evaluating milademetan for MDM2-amplified advanced solid tumors. Treatment...

Logo Benzinga
MarketsBy Vandana Singh2023-11-07 18:23:25
Last November, the FDA signed off Beam Therapeutics Inc's BEAM Investigational New Drug (IND) application for Phase 1/2 trial for BEAM-101 gene therapy for...

Logo Benzinga
MarketsBy Vandana Singh2023-11-08 17:26:45
Avenue Therapeutics Inc ATXI acquired Baergic Bio Inc pursuant to the previously disclosed Share Contribution Agreement with its parent company, Fortress...

Logo Benzinga
MarketsBy Benzinga Insights2023-10-24 16:33:52
CRISPR Therapeutics CRSP has outperformed the market over the past 5 years by 13.48% on an annualized basis producing an average annual return of 21.37%....

Logo Nasdaq
TechnologyBy Zacks2023-10-06 12:45:00
For Immediate Release Chicago, IL October 6, 2023 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-10-19 18:41:08
Plus Therapeutics PSTV is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-10-26 19:32:01
Travere Therapeutics TVTX is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-10-31 15:11:07
Aquestive Therapeutics AQST is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-10-25 20:46:34
Viking Therapeutics VKTX is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-02 19:10:21
Intellia Therapeutics NTLA is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-02 20:16:20
Relay Therapeutics RLAY is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-02 15:18:15
Fate Therapeutics FATE is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-03 18:14:16
Medicenna Therapeutics MDNA is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-07 16:24:57
Voyager Therapeutics VYGR is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the...

Logo ETF Daily News
MarketsBy Market Beat News2024-09-20 06:08:43
Galectin Therapeutics (NASDAQ:GALT – Get Rating) and Dyne Therapeutics (NASDAQ:DYN – Get Rating) are both small-cap medical companies, but which is the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-11-02 14:31:37
Akebia Therapeutics AKBA is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the...
 
AD
AD